Literature DB >> 28395554

Monitoring proteolytic processing events by quantitative mass spectrometry.

Mariel Coradin1, Kelly R Karch1, Benjamin A Garcia1.   

Abstract

INTRODUCTION: Protease activity plays a key role in a wide variety of biological processes including gene expression, protein turnover and development. misregulation of these proteins has been associated with many cancer types such as prostate, breast, and skin cancer. thus, the identification of protease substrates will provide key information to understand proteolysis-related pathologies. Areas covered: Proteomics-based methods to investigate proteolysis activity, focusing on substrate identification, protease specificity and their applications in systems biology are reviewed. Their quantification strategies, challenges and pitfalls are underlined and the biological implications of protease malfunction are highlighted. Expert commentary: Dysregulated protease activity is a hallmark for some disease pathologies such as cancer. Current biochemical approaches are low throughput and some are limited by the amount of sample required to obtain reliable results. Mass spectrometry based proteomics provides a suitable platform to investigate protease activity, providing information about substrate specificity and mapping cleavage sites.

Entities:  

Keywords:  Proteolysis; isotope labeling; mass spectrometry; protease; protease activity; proteomics; substrate recognition

Mesh:

Substances:

Year:  2017        PMID: 28395554      PMCID: PMC5515469          DOI: 10.1080/14789450.2017.1316977

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  91 in total

Review 1.  Top-down MS, a powerful complement to the high capabilities of proteolysis proteomics.

Authors:  Fred W McLafferty; Kathrin Breuker; Mi Jin; Xuemei Han; Giuseppe Infusini; Honghai Jiang; Xianglei Kong; Tadhg P Begley
Journal:  FEBS J       Date:  2007-11-16       Impact factor: 5.542

Review 2.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

Authors:  Jialiang Hu; Philippe E Van den Steen; Qing-Xiang A Sang; Ghislain Opdenakker
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

Review 3.  Matrix metalloproteinases (MMPs) in health and disease: an overview.

Authors:  Charles J Malemud
Journal:  Front Biosci       Date:  2006-05-01

4.  Global identification of peptidase specificity by multiplex substrate profiling.

Authors:  Anthony J O'Donoghue; A Alegra Eroy-Reveles; Giselle M Knudsen; Jessica Ingram; Min Zhou; Jacob B Statnekov; Alexander L Greninger; Daniel R Hostetter; Gang Qu; David A Maltby; Marc O Anderson; Joseph L Derisi; James H McKerrow; Alma L Burlingame; Charles S Craik
Journal:  Nat Methods       Date:  2012-09-30       Impact factor: 28.547

5.  Factor Xa subsite mapping by proteome-derived peptide libraries improved using WebPICS, a resource for proteomic identification of cleavage sites.

Authors:  Oliver Schilling; Ulrich auf dem Keller; Christopher M Overall
Journal:  Biol Chem       Date:  2011-11       Impact factor: 3.915

6.  Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation.

Authors:  Li-Mei Chen; Karl X Chai
Journal:  Int J Cancer       Date:  2002-01-20       Impact factor: 7.396

7.  Global analysis of cellular proteolysis by selective enzymatic labeling of protein N-termini.

Authors:  Arun P Wiita; Julia E Seaman; James A Wells
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 8.  The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.

Authors:  T Kryza; M L Silva; D Loessner; N Heuzé-Vourc'h; J A Clements
Journal:  Biochimie       Date:  2015-09-04       Impact factor: 4.079

Review 9.  Identification and interrogation of combinatorial histone modifications.

Authors:  Kelly R Karch; Jamie E Denizio; Ben E Black; Benjamin A Garcia
Journal:  Front Genet       Date:  2013-12-20       Impact factor: 4.599

10.  Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinoma.

Authors:  Fengming Gong; Xingchen Peng; Can Luo; Guobo Shen; Chengjian Zhao; Liqun Zou; Longhao Li; Yaxiong Sang; Yuwei Zhao; Xia Zhao
Journal:  Mol Cancer       Date:  2013-10-20       Impact factor: 27.401

View more
  3 in total

Review 1.  Approaches to identify and characterize microProteins and their potential uses in biotechnology.

Authors:  Kaushal Kumar Bhati; Anko Blaakmeer; Esther Botterweg Paredes; Ulla Dolde; Tenai Eguen; Shin-Young Hong; Vandasue Rodrigues; Daniel Straub; Bin Sun; Stephan Wenkel
Journal:  Cell Mol Life Sci       Date:  2018-04-18       Impact factor: 9.261

2.  The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin.

Authors:  Azzam Aladdin; Yanhua Yao; Ciyu Yang; Günther Kahlert; Marvi Ghani; Nikolett Király; Anita Boratkó; Karen Uray; Gunnar Dittmar; Krisztina Tar
Journal:  Biomolecules       Date:  2020-11-20

3.  A Systematic Evaluation of Semispecific Peptide Search Parameter Enables Identification of Previously Undescribed N-Terminal Peptides and Conserved Proteolytic Processing in Cancer Cell Lines.

Authors:  Matthias Fahrner; Lucas Kook; Klemens Fröhlich; Martin L Biniossek; Oliver Schilling
Journal:  Proteomes       Date:  2021-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.